Furthermore, overexpression of miR-328-5p significantly decreased FSCN1, phospho-MEK1/2, and phospho-ERK1/2 levels in ESCC cells, but these effects were reversed by miR-328-5p inhibitors (Figure 6B). Here, MAP2K1 is linked to esophageal squamous cell carcinoma.